The link of unintentional weight loss to cardiac event-free survival in patients with heart failure

Journal of Cardiovascular Nursing

Volumn 29, Issue 5, 2014, Pages 439-447

  Song, Eun Kyeung ^a   Lee, Yongjik ^b   Moser, Debra K ^c   Dekker, Rebecca L ^c   Kang, Seok Min ^d   Lennie, Terry A ^d  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Depressive symptoms; Heart failure; High sensitivity C reactive protein; Weight loss

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NUTRITIONAL STATUS; PHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84906092788     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e3182a46ba8     Document Type: Article

References (44)

1. Strassburg S, Springer J, Anker SD. Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol. 2005;37(10): 1938-1947.
2. Pocock SJ, McMurray JJ, Dobson J, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29(21):2641-2650.
3. Filippatos GS, Anker SD, Kremastinos DT. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care. 2005;8(3):249-254.
4. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatmentwith angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077-1083.
5. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349(9058):1050-1053.
6. Filippatos GS, Tsilias K, Venetsanou K, et al. Leptin serum levels in cachectic heart failure patients: relationship with tumor necrosis factor-alpha system. Int J Cardiol. 2000; 76(2-3):117-122.
7. Sandek A, Doehner W, Anker SD, von Haehling S. Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care. 2009;12(4):384-391.
8. Lainscak M, Podbregar M, Anker SD. How does cachexia influence survival in cancer, heart failure and other chronic diseases? Curr Opin Support Palliat Care. 2007;1(4): 299-305.
9. Freeman LM. The pathophysiology of cardiac cachexia. Curr Opin Support Palliat Care. 2009;3(4):276-281.
10. Azhar G, Wei JY. Nutrition and cardiac cachexia. Curr Opin Clin Nutr Metab Care. 2006;9(1):18-23.
11. von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: a systematic overview. Pharmacol Ther. 2009; 121(3):227-252.
12. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002;85(1):51-66.
13. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527-1537.
14. German L, Feldblum I, Bilenko N, Castel H, Harman-Boehm I, Shahar DR. Depressive symptoms and risk for malnutrition among hospitalized elderly people. J Nutr Health Aging. 2008;12(5):313-318.
15. Martin CT, Kayser-Jones J, Stotts NA, Porter C, Froelicher ES. Risk for low weight in community-dwelling, older adults. Clin Nurse Spec. 2007;21(4):203-211; quiz 212-203.
16. Song EK, Moser DK, Payne-Emerson H, et al. Depressive symptoms, poor nutritional intake and event-free survival in patients with heart failure: a deadly chain of events. J Card Fail. 2009;15(65):S5-S6.
17. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793-799.
18. Witte KK, Ford SJ, Preston T, Parker JD, Clark AL. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol. 2008;129(3):363-367.
19. Kop WJ, Synowski SJ, Gottlieb SS. Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin. 2011; 7(1):23-38.
20. Kozdag G, Ertas G, Kilic T, et al. Elevated level of highsensitivity C-reactive protein is important in determining prognosis in chronic heart failure. Med Sci Monit. 2010; 16(3):CR156-CR161.
21. Celik T, Iyisoy A, Celik M, Yuksel UC, Kardesoglu E. C-reactive protein in chronic heart failure: a new predictor of survival. Int J Cardiol. 2009;135(3):396-397.
22. Anand IS, Latini R, Florea VG, et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation. 2005;112(10):1428-1434.
23. Ho K, Anderson K, Kannel W, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-115.
24. Erdfelder E, Faul F, Buchner A. GPOWER: a general power analysis program. Behav Res Methods. 1996;28:1-11.
25. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-191.
26. Rhee MK, Lee YH, Park SH, et al. A standardization study of Beck Depression Inventory 1-Korean version (K-BDI): reliability and factor analysis. Korean J Psychopathol. 1995; 4(1):77-95.
27. Jo SA, Park MH, Jo I, Ryu SH, Han C. Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry. 2007;22(3):218-223.
28. Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003;108(12):e81-e85.
29. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363-369.
30. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-1565.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-383.
32. Mills RM Jr, Haught WH. Evaluation of heart failure patients: objective parameters to assess functional capacity. Clin Cardiol. 1996;19(6):455-460.
33. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341(6):427-434.
34. Strine TW, Mokdad AH, Dube SR, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry. 2008;30(2):127-137.
35. Macht M, Simons G. Emotions and eating in everyday life. Appetite. 2000;35(1):65-71.
36. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246-252.
37. Dallman MF, Pecoraro N, Akana SF, et al. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U S A. 2003;100(20):11696-11701.
38. Grossniklaus DA, Dunbar SB, Tohill BC, Gary R, Higgins MK, Frediani J. Psychological factors are important correlates of dietary pattern in overweight adults. J Cardiovasc Nurs. 2010;25(6):450-460.
39. Anker SD, Coats AJ, Roecker EB, Scherhag A, Packer M. Does carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study. Eur Heart J. 2002;23:394.
40. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005;150(1):132-136.
41. Parissis JT, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004;94(10): 1326-1328.
42. Woods JA, Vieira VJ, Keylock KT. Exercise, inflammation, and innate immunity. Immunol Allergy Clin North Am. 2009;29(2):381-393.
43. Chung ML, Lennie TA, Dekker RL, Wu JR, Moser DK. Depressive symptoms and poor social support have a synergistic effect on event-free survival in patients with heart failure. Heart Lung. 2011;40(6):492-501.
44. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletalmusclewasting. J Clin Investig. 2005;115(2):451-458.